OncoDaily Brings Sarcoma Experts Together at ASCO 2026

Yvonne Awards 2026

OncoDaily Party 2026. CHICAGO LIGHTS

OncoDaily GU - Follow for Curated Updates in Genitourinary Oncology

Grand Rounds by OncoDaily: AI in Oncology Edition

10 Must-Read Posts In GI Oncology This Week

ASCO President Eric Small’s Message to the Global Community Ahead of the ASCO26

Miriam Mutebi: Thoughts From IARC 60 Conference at Lyon

Calculators

Body Mass Index (BMI)

Cockcroft-Gault Creatinine Clearance Calculator

BSA Calculator – Body Surface Area

Carboplatin Dose Calculator (Calvert Formula)

Child-Pugh Score Calculator

ECOG Score Calculator

IBW / Adjusted Body Weight (Devine Formula)

Bone Scan Index (BSI) Tracker

Khorana Score (Cancer-Associated VTE Risk)

MASCC Risk Index Calculator (Febrile Neutropenia)

IMDC Risk Score Calculator (Metastatic RCC)

Oncotype DX Recurrence Score (RS) Categorizer

Cisplatin Cumulative Dose Toxicity Tracker

CTCAE v6.0 Adverse Events Grader

Grade adverse events based on CTCAE v6.0 criteria. Select an adverse event and enter the lab value or clinical finding to determine the severity grade (1-5).

Enter the lab value or clinical finding

CTCAE v6.0 Grade Scale:

  • Grade 1: Mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated.
  • Grade 2: Moderate; minimal, local or noninvasive intervention indicated; limiting instrumental ADL.
  • Grade 3: Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated.
  • Grade 4: Life-threatening consequences; urgent intervention indicated.
  • Grade 5: Death related to AE.